Digital breast tomosynthesis: A brave new world of mammography screening
Menée à partir de données portant sur 23 958 patientes ayant subi au total 44 468 examens de dépistage du cancer du sein entre 2010 et 2014, cette étude compare, du point de vue du taux de rappel, du nombre de cas détectés lors de l'examen de confirmation et du taux de cancer de l'intervalle, l'efficacité d'une tomosynthèse mammaire et d'une mammographie numériques
Little in population health practice has received more scrutiny than mammography screening, and the relentless debate around breast cancer (BC) screening is unlikely to fade as the options of adjunct screening technologies increase. Yet none of the currently available adjunct breast imaging technologies seems as promising, or as feasible to implement on a large scale, as digital breast tomosynthesis (DBT), a pseudo–3-dimensional derivative technology of digital mammography (DM). In fact, this technology appears to be disseminating throughout the United States faster than the pace witnessed for DM in the preceding decade, with 50% of facilities in the Breast Cancer Surveillance Consortium now offering DBT.
JAMA Oncology , éditorial, 2015